Testing effectiveness (Phase 2)WithdrawnNCT02321306
What this trial is testing
An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Who this might be right for
Primary Biliary Cirrhosis
Mirum Pharmaceuticals, Inc.